Meno-ease

The menopause signifies the end of reproductive capacity for a woman, and the years leading up to the menopause, the perimenopause, can bring troublesome symptoms. Once menstruation ceases, typically around the age of 51 for many women, many physical and psychological symptoms can still be experienced. There is no distinct ’cut off’ for perimenopausal symptoms, so there can be an overlap where these symptoms persist alongside specific health issues known to occur in the postmenopausal stage of life. 

IMCD has developed a targeted solution for supporting hormone fluctuations in women of postmenopausal age: Meno ease. 

Meno-ease is a formulation designed to support female hormone fluctuations through the postmenopausal stage of life. This immediate-release tablet contains a combination of clinically proven ingredients that directly influence hormones. Meno-Ease actively promotes healthy menopause, which can significantly impact a woman’s menopausal journey and support overall quality of life.  

Formulated as a combination of clinically proven synergistic actives (Foenix™-Trigonella foenum-graecum, Humulus lupulus L, Isoflav.One® - Glycine max, and 5-methyltetrahydrofolate)